Stay informed — get updates when we publish.
Stay informed. Get updates when we publish.
Fiscal Year 2026
Buprenorphine, methadone, and naltrexone treatment for opioid and alcohol use disorders.
$300,000,000
of Substance Use Programs
VHA MAT Program
FY2026 Budget Data
This is the most detailed level available for this budget item.
Budget data sourced from USAspending.gov and VHA MAT Program.
Fiscal Year 2026 | Last updated: January 2026